Saba Capital adds to Gabelli Healthcare & WellnessRx (GRX) stake

Rhea-AI Filing Summary

Gabelli Healthcare & WellnessRx Trust (GRX) had a Form 4 filed reporting that Saba Capital Management, L.P., a ten percent owner, purchased 24,102 shares of GRX common stock on 2026-08-19 at $10.13 per share in an open-market or private transaction. Following this buy, Saba’s indirectly held position is reported as 2,143,706 shares. The Rule 10b5-1 checkbox was not marked, indicating the trade was not reported as pursuant to a pre-arranged trading plan.

Insider Trade Summary

Net Buyer: 24,102 shares

Net Buy 1 txn

Insider Saba Capital Management, L.P.

Role 10% Owner

Bought 24,102 shs ($244K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	24,102	$10.13	$244K

Holdings After Transaction: Common Stock — 2,143,706 shares (Indirect, -)

Key Figures

Shares purchased: 24,102 shares Purchase price per share: $10.13 Shares held after transaction: 2,143,706 shares

3 metrics

Shares purchased 24,102 shares Common Stock acquired on 2026-08-19 in open-market or private transaction

Purchase price per share $10.13 Per-share price for the 24,102 GRX shares purchased

Shares held after transaction 2,143,706 shares Total indirect GRX common stock holdings reported following the purchase

Key Terms

ten percent owner, indirect ownership, open market or private transaction

3 terms

ten percent owner regulatory

"Saba Capital Management, L.P. is listed as a ten percent owner"

indirect ownership financial

"The transaction is reported with indirect ownership of the shares"

open market or private transaction financial

"Transaction code description notes a purchase in open market or private transaction"

FAQ

What insider transaction in GRX was reported by Saba Capital Management, L.P. on this Form 4?

Saba Capital Management, L.P. reported purchasing 24,102 shares of Gabelli Healthcare & WellnessRx Trust (GRX) common stock. The transaction occurred on 2026-08-19 and is classified as a purchase in an open-market or private transaction, indicating an increase in Saba’s indirect holdings.

At what price did Saba Capital Management, L.P. buy GRX shares on 2026-08-19?

Saba Capital Management, L.P. bought GRX common stock at $10.13 per share. This price is reported as a per-share amount for the 24,102 shares acquired, reflecting the cost basis disclosed for this specific open-market or private transaction in the Form 4.

How many GRX shares does Saba Capital Management, L.P. hold after this reported purchase?

After the reported purchase, Saba Capital Management, L.P. is shown holding 2,143,706 GRX shares indirectly. This figure represents the total indirect ownership in Gabelli Healthcare & WellnessRx Trust common stock as reported following the 24,102-share acquisition on 2026-08-19.

Was Saba Capital Management’s GRX trade made under a Rule 10b5-1 trading plan?

The Form 4 indicates the trade was not under a Rule 10b5-1 plan. The document-level 10b5-1 checkbox is shown as unchecked, meaning the 24,102-share GRX purchase was not reported as executed pursuant to a pre-arranged trading plan.

Is Saba Capital Management, L.P. considered an insider or major holder of GRX?

Saba Capital Management, L.P. is identified as a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX). Ten percent owners are treated as insiders for reporting purposes and must disclose changes in their ownership of GRX securities on Forms 3, 4, and 5.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/20/2026 - 10:22 AM Accepted by SEC EDGAR 08/20/2026 - 10:21 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Saba Capital Management, L.P.

(Last) (First) (Middle)

405 LEXINGTON AVENUE

58TH FLOOR

(Street)

NEW YORK NEW YORK 10174

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Gabelli Healthcare & WellnessRx Trust [ GRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/19/2026		P		24,102	A	$10.13	2,143,706	I	-

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Saba Capital Management, L.P. By: Zachary Gindes	08/20/2026
	Boaz Weinstein	08/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)